Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Medtronic plc | Director | Ordinary Shares | 15.7K | $1.27M | $80.89 | May 1, 2024 | Direct |
Moderna, Inc. | Director | Common Stock | 2.11K | $239K | $113.40 | May 3, 2024 | Direct |
Accolade, Inc. | Director | Common Stock | 37.6K | $156K | $4.15 | Sep 3, 2024 | Direct |
Moderna, Inc. | Director | Restricted Stock Units | 979 | $111K | $113.40 | May 6, 2024 | Direct |
Accolade, Inc. | Director | Restricted Stock Units | 4.36K | $18.1K | $4.15 | Sep 3, 2024 | Direct |
Lyell Immunopharma, Inc. | Director | Option (right to buy) | 130K | Jun 14, 2024 | Direct | ||
Moderna, Inc. | Director | Stock Option (Right to Buy) | 5.67K | May 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACCD | Accolade, Inc. | Sep 3, 2024 | 2 | $0 | 4 | Sep 5, 2024 | Director |
ACCD | Accolade, Inc. | Aug 6, 2024 | 2 | $0 | 4 | Aug 8, 2024 | Director |
ACCD | Accolade, Inc. | Aug 6, 2024 | 1 | $0 | 4 | Aug 8, 2024 | Director |
LYEL | Lyell Immunopharma, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
ACCD | Accolade, Inc. | May 31, 2024 | 2 | $0 | 4 | Jun 3, 2024 | Director |
MRNA | Moderna, Inc. | May 3, 2024 | 4 | $0 | 4 | May 7, 2024 | Director |
MDT | Medtronic plc | May 1, 2024 | 1 | -$15.5K | 4 | May 3, 2024 | Director |
MDT | Medtronic plc | Apr 29, 2024 | 1 | $175K | 4 | May 1, 2024 | Director |
ACCD | Accolade, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 5, 2024 | Director |
ACCD | Accolade, Inc. | Feb 29, 2024 | 2 | $0 | 4 | Mar 4, 2024 | Director |
ACCD | Accolade, Inc. | Nov 30, 2023 | 2 | $0 | 4 | Dec 4, 2023 | Director |
LYEL | Lyell Immunopharma, Inc. | Sep 8, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Director |
ACCD | Accolade, Inc. | Aug 31, 2023 | 2 | $0 | 4 | Aug 31, 2023 | Director |
ACCD | Accolade, Inc. | Aug 18, 2023 | 1 | $0 | 4 | Aug 22, 2023 | Director |
ACCD | Accolade, Inc. | Jul 25, 2023 | 2 | $0 | 4 | Jul 27, 2023 | Director |
LYEL | Lyell Immunopharma, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
ACCD | Accolade, Inc. | May 31, 2023 | 2 | $0 | 4 | Jun 1, 2023 | Director |
MRNA | Moderna, Inc. | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
MDT | Medtronic plc | May 1, 2023 | 2 | $160K | 4 | May 3, 2023 | Director |
MRNA | Moderna, Inc. | Apr 28, 2023 | 2 | $0 | 4 | May 1, 2023 | Director |
ACCD | Accolade, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Director |
ACCD | Accolade, Inc. | Jul 26, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Director |
ACCD | Accolade, Inc. | Jul 21, 2022 | 2 | $0 | 4 | Jul 25, 2022 | Director |
LYEL | Lyell Immunopharma, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
MDT | Medtronic plc | May 2, 2022 | 2 | -$27K | 4 | May 4, 2022 | Director |
MRNA | Moderna, Inc. | Apr 28, 2022 | 4 | $0 | 4 | May 2, 2022 | Director |
ACCD | Accolade, Inc. | Jul 22, 2021 | 3 | $0 | 4 | Jul 26, 2021 | Director |
LYEL | Lyell Immunopharma, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |
ACCD | Accolade, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |
ACCD | Accolade, Inc. | Jun 2, 2021 | 0 | $0 | 3 | Jun 3, 2021 | Director |